anti-CD95 |
|||
| YF-PA10284 | Abfrontier | 100 ul | EUR 403 |
|
Description: Rabbit polyclonal to CD95 |
|||
anti-CD95 |
|||
| YF-PA10285 | Abfrontier | 100 ug | EUR 403 |
|
Description: Rabbit polyclonal to CD95 |
|||
anti-CD95 |
|||
| YF-PA23234 | Abfrontier | 50 ul | EUR 334 |
|
Description: Mouse polyclonal to CD95 |
|||
CD95 antibody |
|||
| 20R-1441 | Fitzgerald | 100 ug | EUR 673 |
|
Description: Rabbit polyclonal Fas 1/Apo 1 antibody |
|||
CD95 antibody |
|||
| 10R-6452 | Fitzgerald | 50 ug | EUR 181 |
|
Description: Mouse monoclonal CD95 antibody |
|||
CD95 antibody |
|||
| 70R-11592 | Fitzgerald | 100 ug | EUR 403 |
|
Description: Rabbit polyclonal CD95 antibody |
|||
CD95 antibody |
|||
| 70R-49386 | Fitzgerald | 100 ul | EUR 244 |
|
Description: Purified Polyclonal CD95 antibody |
|||
CD95 Polyclonal Antibody |
|||
| ES1920-100ul | ELK Biotech | 100ul | EUR 279 |
|
Description: A Rabbit Polyclonal antibody against CD95 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
CD95 Polyclonal Antibody |
|||
| ES1920-50ul | ELK Biotech | 50ul | EUR 207 |
|
Description: A Rabbit Polyclonal antibody against CD95 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
CD95 Polyclonal Antibody |
|||
| ABP50921-003ml | Abbkine | 0.03ml | EUR 158 |
|
Description: A polyclonal antibody for detection of CD95 from Human. This CD95 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human CD95 at AA range: 250-330 |
|||
CD95 Polyclonal Antibody |
|||
| ABP50921-01ml | Abbkine | 0.1ml | EUR 289 |
|
Description: A polyclonal antibody for detection of CD95 from Human. This CD95 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human CD95 at AA range: 250-330 |
|||
CD95 Polyclonal Antibody |
|||
| ABP50921-02ml | Abbkine | 0.2ml | EUR 414 |
|
Description: A polyclonal antibody for detection of CD95 from Human. This CD95 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human CD95 at AA range: 250-330 |
|||
CD95 Blocking Peptide |
|||
| 20-abx062261 | Abbexa |
|
|
CD95 Antibody (FITC) |
|||
| abx139052-100tests | Abbexa | 100 tests | EUR 425 |
Anti-CD95 antibody |
|||
| STJ92150 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to CD95. |
|||
CD95 Polyclonal Antibody |
|||
| 40709-100ul | SAB | 100ul | EUR 252 |
CD95 Polyclonal Antibody |
|||
| 40709-50ul | SAB | 50ul | EUR 187 |
CD95 / Fas Antibody |
|||
| 48282-100ul | SAB | 100ul | EUR 333 |
CD95 / Fas Antibody |
|||
| 48282-50ul | SAB | 50ul | EUR 239 |
Fas(CD95) Antibody |
|||
| 49307-100ul | SAB | 100ul | EUR 333 |
Fas(CD95) Antibody |
|||
| 49307-50ul | SAB | 50ul | EUR 239 |
Anti-CD95 (5B4) |
|||
| YF-MA11963 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to CD95 |
|||
Anti-CD95 (1D6) |
|||
| YF-MA11964 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to CD95 |
|||
Anti-CD95 (2D8) |
|||
| YF-MA11965 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to CD95 |
|||
Anti-CD95 (3B9) |
|||
| YF-MA11966 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to CD95 |
|||
Anti-CD95 (6D4) |
|||
| YF-MA11968 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to CD95 |
|||
Anti-CD95 (7F12) |
|||
| YF-MA11969 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to CD95 |
|||
Anti-CD95 (3D7) |
|||
| YF-MA11970 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to CD95 |
|||
Anti-CD95 (1B6) |
|||
| YF-MA11971 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to CD95 |
|||
CD95 antibody (PE) |
|||
| 61R-1287 | Fitzgerald | 200 ug | EUR 478 |
|
Description: Mouse monoclonal CD95 antibody (PE) |
|||
CD95 antibody (biotin) |
|||
| 61R-1542 | Fitzgerald | 50 ug | EUR 181 |
|
Description: Mouse monoclonal CD95 antibody (biotin) |
|||
CD95 Blocking Peptide |
|||
| 33R-10615 | Fitzgerald | 50 ug | EUR 191 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CD95 antibody, catalog no. 70R-11592 |
|||
CD95 Recombinant Protein |
|||
| 96-301 | ProSci | 0.05 mg | EUR 516.5 |
|
Description: The Fas is also known as FAS receptor (FasR), apoptosis antigen 1 (APO-1 or APT), cluster of differentiation 95 (CD95) or tumor necrosis factor receptor superfamily member 6 (TNFRSF6). is a death receptor on the surface of cells that leads to programmed cell death (apoptosis). It is one of two apoptosis pathways, the other being the mitochondrial pathway. FasR is located on chromosome 10 in humans and 19 in mice. Similar sequences related by evolution (orthologs) are found in most mammals. Fas forms the death-inducing signaling complex (DISC) upon ligand binding. Membrane-anchored Fas ligand trimer on the surface of an adjacent cell causes trimerization of Fas receptor. This event is also mimicked by binding of an agonistic Fas antibody, though some evidence suggests that the apoptotic signal induced by the antibody is unreliable in the study of Fas signaling. To this end, several clever ways of trimerizing the antibody for in vitro research have been employed.Upon ensuing death domain (DD) aggregation, the receptor complex is internalized via the cellular endosomal machinery. This allows the adaptor molecule FADD to bind the death domain of Fas through its own death domain. Recently, Fas has also been shown to promote tumor growth, since during tumor progression, it is frequently downregulated or cells are rendered apoptosis resistant. Cancer cells in general, regardless of their Fas apoptosis sensitivity, depend on constitutive activity of Fas. This is stimulated by cancer-produced Fas ligand for optimal growth. |
|||
CD95 Recombinant Protein |
|||
| 96-302 | ProSci | 0.1 mg | EUR 516.5 |
|
Description: The Fas is also known as FAS receptor (FasR), apoptosis antigen 1 (APO-1 or APT), cluster of differentiation 95 (CD95) or tumor necrosis factor receptor superfamily member 6 (TNFRSF6). is a death receptor on the surface of cells that leads to programmed cell death (apoptosis). It is one of two apoptosis pathways, the other being the mitochondrial pathway. FasR is located on chromosome 10 in humans and 19 in mice. Similar sequences related by evolution (orthologs) are found in most mammals. Fas forms the death-inducing signaling complex (DISC) upon ligand binding. Membrane-anchored Fas ligand trimer on the surface of an adjacent cell causes trimerization of Fas receptor. This event is also mimicked by binding of an agonistic Fas antibody, though some evidence suggests that the apoptotic signal induced by the antibody is unreliable in the study of Fas signaling. To this end, several clever ways of trimerizing the antibody for in vitro research have been employed.Upon ensuing death domain (DD) aggregation, the receptor complex is internalized via the cellular endosomal machinery. This allows the adaptor molecule FADD to bind the death domain of Fas through its own death domain. Recently, Fas has also been shown to promote tumor growth, since during tumor progression, it is frequently downregulated or cells are rendered apoptosis resistant. Cancer cells in general, regardless of their Fas apoptosis sensitivity, depend on constitutive activity of Fas. This is stimulated by cancer-produced Fas ligand for optimal growth. |
|||
CD95 Recombinant Protein |
|||
| 91-803 | ProSci | 0.05 mg | EUR 490.25 |
|
Description: FAS is a receptor and contains three TNFR-Cys repeats and one death domain. It has been shown that FAS is involved in the physiological regulation of programmed cell death, and has been implicated in the pathogenesis of various malignancies and diseases of the immune system. FADD (adapter molecule) recruits caspase-8 to the activated receptor, the resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases mediating apoptosis. FAS-mediated apoptosis may play a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. |
|||
Anti-Hu CD95 Purified |
|||
| 11-362-C025 | ExBio | 0.025 mg | EUR 99 |
Anti-Hu CD95 Purified |
|||
| 11-362-C100 | ExBio | 0.1 mg | EUR 158 |
Anti-Hu CD95 Purified |
|||
| 11-753-C025 | ExBio | 0.025 mg | EUR 99 |
Anti-Hu CD95 Purified |
|||
| 11-753-C100 | ExBio | 0.1 mg | EUR 158 |
Anti-Hu CD95 APC |
|||
| 1A-362-T025 | ExBio | 25 tests | EUR 140 |
Anti-Hu CD95 APC |
|||
| 1A-362-T100 | ExBio | 100 tests | EUR 240 |
Anti-Hu CD95 FITC |
|||
| 1F-362-T025 | ExBio | 25 tests | EUR 122 |
Anti-Hu CD95 FITC |
|||
| 1F-362-T100 | ExBio | 100 tests | EUR 204 |
Anti-Hu CD95 PE |
|||
| 1P-362-T025 | ExBio | 25 tests | EUR 140 |
Anti-Hu CD95 PE |
|||
| 1P-362-T100 | ExBio | 100 tests | EUR 240 |
CD95(B-R18) Antibody |
|||
| BNC040305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC040305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC470305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC470305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC550305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC550305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNCB0305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNCB0305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC810305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC810305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), CF680R conjugate, Concentration: 0.1mg/mL |
|||
FAS (CD95) Blocking Antibody |
|||
| 20-abx137005 | Abbexa |
|
|
CD95(B-R18) Antibody |
|||
| BNC700305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC700305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC880305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC880305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC940305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC940305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC680305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC680305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNCA0305-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against CD95(B-R18), APC conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNCAP0305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNCAP0305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNUM0305-50 | Biotium | 50uL | EUR 395 |
|
Description: Primary antibody against CD95(B-R18), 1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNCP0305-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against CD95(B-R18), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC050305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC050305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC400305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC400305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNCR0305-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against CD95(B-R18), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNUB0305-100 | Biotium | 100uL | EUR 209 |
|
Description: Primary antibody against CD95(B-R18), Concentration: 0.2mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNUB0305-500 | Biotium | 500uL | EUR 458 |
|
Description: Primary antibody against CD95(B-R18), Concentration: 0.2mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC430305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC430305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNCH0305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNCH0305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC610305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC610305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC800305-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD95(B-R18), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD95(B-R18) Antibody |
|||
| BNC800305-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD95(B-R18), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Anti-FAS / CD95 antibody |
|||
| STJ72023 | St John's Laboratory | 100 µg | EUR 359 |
anti- FAS/CD95 antibody |
|||
| FNab03016 | FN Test | 100µg | EUR 585 |
|
Description: Antibody raised against FAS/CD95 |
|||
anti- FAS/CD95 antibody |
|||
| FNab03017 | FN Test | 100µg | EUR 548.75 |
|
Description: Antibody raised against FAS/CD95 |
|||
Recombinant (E.Coli) Human CD95 |
|||
| RP-943 | Alpha Diagnostics | 2 ug | EUR 347 |
Anti-FAS/CD95 antibody |
|||
| PAab03016 | Lifescience Market | 100 ug | EUR 412 |
CD95 Ligand antibody (PE) |
|||
| 61R-1378 | Fitzgerald | 100 ug | EUR 322 |
|
Description: Armenian Hamster monoclonal CD95 Ligand antibody (PE) |
|||